<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-051962</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Intramural aortic hematoma and anticoagulation</dc:title>
<dc:description xml:lang="en">Intramural aortic hematoma is one of a group of conditions covered by the term acute aortic syndrome. Many aspects of its natural history remain poorly understood, and the best treatment is not known. The aim of this study was to describe the clinical and radiological characteristics and follow-up of a group of patients with intramural aortic hematoma who received anticoagulant therapy during hospitalization. We selected a prospective cohort of patients with a diagnosis of intramural aortic hematoma and carried out an analysis of those who received anticoagulation treatment during the acute phase of the illness. Patients received anticoagulation for a range of different reasons. In all patients, the intramural aortic hematoma was observed to undergo gradual regression despite anticoagulation therapy</dc:description>
<dc:creator>Bustos, Ana</dc:creator>
<dc:creator>Rodríguez, Enrique</dc:creator>
<dc:creator>Ferreirós, Joaquín</dc:creator>
<dc:creator>Díaz-Mediavilla, Joaquín</dc:creator>
<dc:creator>Vilacosta, Isidre</dc:creator>
<dc:creator>Cañadas, María Victoria</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">El hematoma intramural (HIA) forma parte del espectro de lesiones del síndrome aórtico agudo. Hay múltiples aspectos no bien conocidos acerca de su historia natural y del tratamiento óptimo. El objetivo de este artículo es describir las características clínicas, radiológicas y el seguimiento de un grupo de pacientes con HIA que recibieron tratamiento anticoagulante durante el ingreso. Se recogió información de forma prospectiva en todos los pacientes con el diagnóstico de HIA y se analizó a los que recibieron tratamiento anticoagulante durante la fase aguda de la enfermedad. Las indicaciones de dicho tratamiento fueron variadas. En todos ellos se comprobó una regresión progresiva del HIA a pesar del tratamiento anticoagulante recibido</dc:description>
<dc:source>Rev Esp Cardiol;60(2): 201-204, feb. 2007. ilus, tab</dc:source>
<dc:identifier>ibc-051962</dc:identifier>
<dc:title xml:lang="es">Hematoma intramural aórtico y anticoagulación</dc:title>
<dc:subject>^d932^s28898</dc:subject>
<dc:subject>^d1018^s22058</dc:subject>
<dc:subject>^d4691^s22057</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d24375</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:subject>^d932^s22000</dc:subject>
<dc:type>article</dc:type>
<dc:date>200702</dc:date>
</metadata>
</record>
</ibecs-document>
